TE, Y., MS, K., MA, E. M., T, E., JB, T., EK, M., . . . AK, L. (2024). Hyaluronic acid turnover controls the severity of cerebral cavernous malformations in bioengineered human micro-vessels. APL bioengineering, 8(1), 016108. https://doi.org/10.1063/5.0159330
Chicago Style (17th ed.) CitationTE, Yordanov, et al. "Hyaluronic Acid Turnover Controls the Severity of Cerebral Cavernous Malformations in Bioengineered Human Micro-vessels." APL Bioengineering 8, no. 1 (2024): 016108. https://doi.org/10.1063/5.0159330.
MLA (9th ed.) CitationTE, Yordanov, et al. "Hyaluronic Acid Turnover Controls the Severity of Cerebral Cavernous Malformations in Bioengineered Human Micro-vessels." APL Bioengineering, vol. 8, no. 1, 2024, p. 016108, https://doi.org/10.1063/5.0159330.
Warning: These citations may not always be 100% accurate.
